Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Terminated 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gynecologic 1

Conditions

Esophageal Squamous Cell Carcinoma 11Esophageal Neoplasms 5Uterine Cervical Neoplasms 4Carcinoma, Non-Small-Cell Lung 3Squamous Cell Carcinoma of Head and Neck 2Neoplasm Metastasis 2Lymphatic Metastasis 2Uterine Neoplasms 1Triple Negative Breast Neoplasms 1Thyroid Neoplasms 1Thymoma 1Thymic epithelial tumor 1Solid Tumor Cancer 1Recurrence 1Pathologic Complete Response 1Ovarian Neoplasms 1Neoplasms 1Neoplasm Recurrence, Local 1Nasopharyngeal Carcinoma 1Mouth Neoplasms 1Melanoma 1Lung Neoplasms 1Head and Neck Neoplasms 1Fallopian Tube Neoplasms 1Endometrial Neoplasms 1Carcinoma, Squamous Cell 1Carcinoma, Ductal, Breast 1Breast Neoplasms 1

Interventions

Carboplatin 75Paclitaxel 68Bevacizumab 44Taxes 22Cyclophosphamide 21pembrolizumab 19Gemcitabine 19Cisplatin 18Topotecan 17Hyperthermic Intraperitoneal Chemotherapy 14olaparib 13liposomal doxorubicin 13Immunoglobulin G 13Disulfides 13Specimen Handling 11Drug Therapy 11niraparib 10Cytoreduction Surgical Procedures 10Magnetic Resonance Spectroscopy 9sargramostim 7Surveys and Questionnaires 7Doxorubicin 7Docetaxel 7durvalumab 6Platinum 6Nivolumab 6Letrozole 6Granulocyte-Macrophage Colony-Stimulating Factor 6Biopsy 6Albumin-Bound Paclitaxel 6

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
OTHER × Fallopian Tube Neoplasms × TP protocol × Clear all
NCT00582205 2021-05-19

Feasibility Trial of Intraperitoneal Chemotherapy for Ovarian, Fallopian Tube, and Primary Peritoneal Carcinoma

University of Oklahoma

Phase 2 Terminated
21 enrolled 7 charts
Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Uterine Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡